9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Eastern Cooperative Oncology Group
University of Southern California
UNC Lineberger Comprehensive Cancer Center
The University of Texas Health Science Center at San Antonio
Washington University School of Medicine
Tempus AI